Immunis

Organisation

People

Sources: assets-us-01.kc-usercontent.com

Board

Sources: sec.gov

Based in

  • United States

Sources: assets-us-01.kc-usercontent.com

Funding rounds

  • Form D

    US$20.4m, 17 Jun 2024

Sources: sec.gov

Investors

Sources: agingbio.app

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov